Pan European Collaboration on Antipsychotic Naïve Schizophrenia II
Status:
Completed
Trial end date:
2021-01-01
Target enrollment:
Participant gender:
Summary
The study is a prospective 2 year multimodal follow-up study of initially antipsychotic-naïve
first-episode psychotic patients involving a standardized intervention with monotherapy with
aripiprazole during the first 6 weeks. Patients and matched healthy controls will be examined
after 6 weeks, 6 months and 2 years. They will be examined with MR-scannings, neurocognitive
tests, EEG, and PET-scannings.